Prognostic importance of DNA flow cytometrical, histopathological and immunohistochemical parameters in neuroblastomas (original) (raw)

Neuronal and glial markers in tumours of neuroblastic origin

Virchows Archiv A Pathological Anatomy and Histopathology, 1984

Cytogenic investigations in the assessment of response to treatment in neuroblastoma

Journal of Clinical Pathology, 1987

Detection of microscopic neuroblastoma in marrow by histology, immunocytology, and reverse transcription-PCR of multiple molecular markers

Nai-Kong Cheung

Clinical cancer research : an official journal of the American Association for Cancer Research, 1998

View PDFchevron_right

Biochemical evidence for a mature phenotype in morphologically poorly differentiated neuroblastomas with a favourable outcome

Bengt Sandstedt

European Journal of Cancer, 1995

View PDFchevron_right

Molecular Characteristics of Neuroblastoma with Special Reference to Novel Prognostic Factors and Diagnostic Applications

Miikka Korja

View PDFchevron_right

Brodeur GM, Pritchard J, Berthold F, Carlsen NL, Carlsen V, Castelberry RP, De Bernardi B, Evans AE, Favrot M, Hedborg F, Kaneko M, Tsuchida Y, Philip T, Roald B, Voute PARevisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 11: 1466...

Garrett Brodeur

Journal of Clinical Oncology

View PDFchevron_right

Neuroblastoma: A study of the clinicopathologic characteristics and prognosis based on Mitotic Karyorrhectic Index

Prema N S, IP Innovative Publication Pvt. Ltd.

IP innovative publication pvt. ltd, 2019

View PDFchevron_right

Immunoexpression of cell cycle biomarkers in neuroblastoma samples and its correlation with prognostic factors

Deli Araújo

Jornal Brasileiro de Patologia e Medicina Laboratorial, 2013

View PDFchevron_right

S-100 Protein Expression Levels as a Potential Prognostic Marker in Neuroblastoma

Zekiye Altun

Sabiad, 2022

View PDFchevron_right

The International Neuroblastoma Pathology Classification (the Shimada system)

Hiroyuki Shimada, Borghild Roald

Cancer, 1999

View PDFchevron_right

Clinical relevance of molecular markers in neuroblastoma: results from a single institution

Francina Munell

Oncology Reports, 1999

View PDFchevron_right

International consensus for neuroblastoma molecular diagnostics: Report from the International Neuroblastoms Risk Grouping (INRG) biology committee

Javed M Khan

View PDFchevron_right

Neuron-specific enolase in relation to differentiation in human neuroblastoma

Göran Läckgren

Brain Research, 1981

View PDFchevron_right

A comparative analysis of nuclear DNA content and N-myc gene amplification in neuroblastoma

Joseph Locker

Cancer, 1990

View PDFchevron_right

Flow Cytometry Analysis of Neural Differentiation Markers Expression in Human Glioblastomas May Predict Their Response to Chemotherapy

Igor Sulla

Cellular and Molecular Neurobiology, 2009

View PDFchevron_right

International consensus for neuroblastoma molecular diagnostics: Report from the international neuroblastoma risk grouping (INRG) Biology committee

Javed M Khan

View PDFchevron_right

Rapid detection of prognostic genetic factors in neuroblastoma using fluorescence in situ hybridisation on tumour imprints and bone marrow smears

Denise Sheer

British Journal of Cancer, 1994

View PDFchevron_right

International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee

Javed M Khan

British journal of …, 2009

View PDFchevron_right

Cytogenetic evaluation of neuroblastoma using fine needle aspiration cultures

Sandeep Agarwala

2009

View PDFchevron_right

A comparative analysis of nuclear DNA and N-myc gene amplification in neuroblastoma

Joseph Locker

Cancer

View PDFchevron_right

Profile of Neuron-Specific Enolase, Lactate Dehydrogenase, Fine Needle Aspiration Biopsy, and Bone Marrow Aspiration Examination to Diagnose Neuroblastoma Patients in Hematology Oncology Division of Pediatric Department at Dr. Soetomo General Hospital

dewa gede ugrasena

Indonesian Journal of Cancer, 2019

View PDFchevron_right

Standardization of the Immunocytochemical Detection of Neuroblastoma Cells in Bone Marrow

Gross Nicole, Peter Ambros

Journal of Histochemistry and Cytochemistry, 2005

View PDFchevron_right

Experience with International Neuroblastoma Staging System and Pathology Classification

Jun-ichi Hata

British Journal of Cancer, 2002

View PDFchevron_right

Identification of Subsets of Neuroblastomas by Combined Histopathologic and N-myc Analysis

Garrett Brodeur

JNCI Journal of the National Cancer Institute, 1995

View PDFchevron_right

Identification and Characterization of Genetic Alterations in Neuroblastoma and their Prognostic Relevance

Fakhera Ikram

2014

View PDFchevron_right

How to minimise the effect of tumour cell content in detection of aberrant genetic markers in neuroblastoma

Marta Piqueras

British journal of cancer, 2011

View PDFchevron_right

Tumour markers are poor predictors for relapse or progression in neuroblastoma

Frank Berthold

European Journal of Cancer, 2003

View PDFchevron_right

Detection of N-myc Amplification in Neuroblastomas Using Southern Blotting on Fine Needle Aspirates

Luís Cirnes

Acta Cytologica, 2001

View PDFchevron_right

The Detection of Genetic Parameters for Prognostic Stratification of Neuroblastoma Using Multiplex Ligation-Dependent Probe Amplification Technique

Sait Tümer

Genetic Testing and Molecular Biomarkers, 2016

View PDFchevron_right

Molecular basis for heterogeneity in human neuroblastomas

Garrett Brodeur

European Journal of Cancer, 1995

View PDFchevron_right

Anatomic Origin and Molecular Genetics in Neuroblastoma

Ozan Durmaz

Neuroblastoma - Current State and Recent Updates

View PDFchevron_right

Modal DNA content of human intracranial neoplasms studied by flow cytometry

Ole Laerum

Journal of Neurosurgery, 1980

View PDFchevron_right

Determination of genomic damage in neuroblastic tumors by arbitrarily primed PCR: MYCN amplification as a marker for genomic instability in neuroblastomas

Miguel Angel Fernández Peinado

Neuropathology, 2006

View PDFchevron_right

First experience with prognostic factors in unselected neuroblastoma patients. The Austrian neuroblastoma 87 study

I. Mutz

European Journal of Cancer, 1995

View PDFchevron_right

Prognostic importance of DNA flow cytometrical, histopathological and immunohistochemical parameters in neuroblastomas (original) (raw)

Related papers